Does LOMUSTINE Cause Hepatocellular injury? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Hepatocellular injury have been filed in association with LOMUSTINE (LOMUSTINE). This represents 1.2% of all adverse event reports for LOMUSTINE.
20
Reports of Hepatocellular injury with LOMUSTINE
1.2%
of all LOMUSTINE reports
0
Deaths
4
Hospitalizations
How Dangerous Is Hepatocellular injury From LOMUSTINE?
Of the 20 reports, 4 (20.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMUSTINE. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does LOMUSTINE Cause?
Death (169)
Off label use (135)
Thrombocytopenia (127)
Disease progression (106)
Neutropenia (92)
Drug ineffective (88)
Fatigue (71)
Nausea (68)
Platelet count decreased (63)
Malignant neoplasm progression (62)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
ATORVASTATIN (610)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
Which LOMUSTINE Alternatives Have Lower Hepatocellular injury Risk?
LOMUSTINE vs LONAPEGSOMATROPIN-TCGD
LOMUSTINE vs LONCASTUXIMAB TESIRINE-LPYL
LOMUSTINE vs LOPERAMIDE
LOMUSTINE vs LOPINAVIR
LOMUSTINE vs LOPINAVIR\RITONAVIR